These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28115589)

  • 1. Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation.
    Bettencourt IA; Powell JD
    J Immunol; 2017 Feb; 198(3):999-1005. PubMed ID: 28115589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity.
    Yun TJ; Harning EK; Giza K; Rabah D; Li P; Arndt JW; Luchetti D; Biamonte MA; Shi J; Lundgren K; Manning A; Kehry MR
    J Immunol; 2011 Jan; 186(1):563-75. PubMed ID: 21131419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity.
    Mohammadnezhad L; Shekarkar Azgomi M; La Manna MP; Sireci G; Rizzo C; Badami GD; Tamburini B; Dieli F; Guggino G; Caccamo N
    Cells; 2022 May; 11(10):. PubMed ID: 35626700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting autoimmunity: strategies and tactics.
    Masuda ES; Payan DG
    Drug Discov Today; 2014 Aug; 19(8):1193-4. PubMed ID: 24886764
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapies Targeting Trained Immune Cells in Inflammatory and Autoimmune Diseases.
    Municio C; Criado G
    Front Immunol; 2020; 11():631743. PubMed ID: 33569065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting T cell metabolism to regulate T cell activation, differentiation and function in disease.
    Patel CH; Powell JD
    Curr Opin Immunol; 2017 Jun; 46():82-88. PubMed ID: 28521236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1: A Potential Therapeutic Target in Autoimmune Diseases.
    Shen P; Deng X; Chen Z; Ba X; Qin K; Huang Y; Huang Y; Li T; Yan J; Tu S
    Front Immunol; 2021; 12():779177. PubMed ID: 34887866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic regulation of pathogenic autoimmunity: therapeutic targeting.
    Teng X; Cornaby C; Li W; Morel L
    Curr Opin Immunol; 2019 Dec; 61():10-16. PubMed ID: 31422315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycolysis in Innate Immune Cells Contributes to Autoimmunity.
    Xu Y; Chen Y; Zhang X; Ma J; Liu Y; Cui L; Wang F
    Front Immunol; 2022; 13():920029. PubMed ID: 35844594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming & inflammation: Fuelling the host response to pathogens.
    Gleeson LE; Sheedy FJ
    Semin Immunol; 2016 Oct; 28(5):450-468. PubMed ID: 27780657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HHX-5, a derivative of sesquiterpene from Chinese agarwood, suppresses innate and adaptive immunity via inhibiting STAT signaling pathways.
    Zhu Z; Zhao Y; Huo H; Gao X; Zheng J; Li J; Tu P
    Eur J Pharmacol; 2016 Nov; 791():412-423. PubMed ID: 27640747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting metabolism to regulate immune responses in autoimmunity and cancer.
    Patel CH; Leone RD; Horton MR; Powell JD
    Nat Rev Drug Discov; 2019 Sep; 18(9):669-688. PubMed ID: 31363227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific and Complex Reprogramming of Cellular Metabolism in Myeloid Cells during Innate Immune Responses.
    Stienstra R; Netea-Maier RT; Riksen NP; Joosten LAB; Netea MG
    Cell Metab; 2017 Jul; 26(1):142-156. PubMed ID: 28683282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel compounds to treat autoimmune and inflammatory diseases and graft versus host reactions.
    Appel S; Brossart P
    Endocr Metab Immune Disord Drug Targets; 2007 Jun; 7(2):93-7. PubMed ID: 17584149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of innate immune memory: the role of cellular metabolism.
    Domínguez-Andrés J; Joosten LA; Netea MG
    Curr Opin Immunol; 2019 Feb; 56():10-16. PubMed ID: 30240964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
    Tsai HC; Han MH
    Drugs; 2016 Jul; 76(11):1067-79. PubMed ID: 27318702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylases as regulators of inflammation and immunity.
    Shakespear MR; Halili MA; Irvine KM; Fairlie DP; Sweet MJ
    Trends Immunol; 2011 Jul; 32(7):335-43. PubMed ID: 21570914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navigating immune cell immunometabolism after liver transplantation.
    Zhang W; Liu Z; Xu X
    Crit Rev Oncol Hematol; 2021 Apr; 160():103227. PubMed ID: 33675906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trained immunity: A smart way to enhance innate immune defence.
    van der Meer JW; Joosten LA; Riksen N; Netea MG
    Mol Immunol; 2015 Nov; 68(1):40-4. PubMed ID: 26597205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.
    Jordan SC; Choi J; Kim I; Wu G; Toyoda M; Shin B; Vo A
    Transplantation; 2017 Jan; 101(1):32-44. PubMed ID: 27547870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.